The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Churg–Strauss syndrome
Abstract
PURPOSE OF REVIEW: Churg-Strauss syndrome is a small-vessel necrotizing vasculitis typically characterized by asthma, lung infiltrates, extravascular necrotizing granulomas and hypereosinophilia. The most recent clinical studies on its pathogenesis and therapeutic management are reviewed here. RECENT FINDINGS: French and Italian clinical studies found that the clinical characteristics of patients with Churg-Strauss syndrome differed according to their antineutrophil cytoplasmic autoantibody status: cardiomyopathy predominated in antineutrophil cytoplasmic autoantibody-negative patients while necrotizing glomerulonephritis was more often observed in antineutrophil cytoplasmic autoantibody-positive patients. These histologically documented findings suggest the existence of different Churg-Strauss syndrome subtypes, characterized by the predominance of distinct pathogenetic mechanisms. To date, following the therapeutic recommendations for Churg-Strauss syndrome (i.e. corticosteroids and, when required, immunosuppressants), patient outcomes are good, with 5-year survival exceeding 90%, but often with the need to continue low-dose corticosteroids to control residual asthma. SUMMARY: The precise pathogenetic mechanisms of Churg-Strauss syndrome are only partly elucidated. Recent results suggest that antineutrophil cytoplasmic autoantibodies are probably more involved in the vasculitic manifestations of Churg-Strauss syndrome (e.g. glomerulonephritis) whereas eosinophil tissue infiltration and associated cytotoxicity would be responsible for cardiomyopathy. If confirmed, these results could support individual therapeutic stratification according to the clinical pattern. Furthermore, some patients may benefit from new biologic therapies under development, for example antiinterleukin-5 or antiimmunoglobulin E monoclonal antibodies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jayne, D., Rasmussen, N., Andrassy, K., Bacon, P., Tervaert, J. W. C., Dadoniené, J., Ekstrand, A., Gaskin, G., Gregorini, G., de Groot, K., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020286 · Cited by 1,348
What is known about the epidemiology of the vasculitides?
Watts, R. A., Lane, S., & Scott, D. G. I. (2005) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2004.11.006 · Cited by 178
Cited by
Comarmond, C., Pagnoux, C., Khellaf, M., Cordier, J., Hamidou, M., Viallard, J., Maurier, F., Jouneau, S., Bienvenu, B., Puéchal, X., et al. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37721 · Cited by 937
Self-citationRibi, C., Cohen, P., Pagnoux, C., Mahr, A., Arène, J., Lauque, D., Puéchal, X., Letellier, P., Delaval, P., Cordier, J., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23198 · Cited by 335
Self-citationGreco, A., Rizzo, M. I., De Virgilio, A., Gallo, A., Fusconi, M., Ruoppolo, G., Altissimi, G., & De Vincentiis, M. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.12.004 · Cited by 293
Eosinophilic granulomatosis with polyangiitis (Churg–Strauss): state of the art
Vaglio, A., Buzio, C., & Zwerina, J. (2013) · Allergy · doi:10.1111/all.12088 · Cited by 284
Update on eosinophilic granulomatosis with polyangiitis
Furuta, S., Iwamoto, T., & Nakajima, H. (2019) · Allergology International · doi:10.1016/j.alit.2019.06.004 · Cited by 258
Metadata
- Authors
- Pagnoux, C., Guilpain, P., & Guillevin, L.
- Venue
- Current Opinion in Rheumatology
- Published
- 2007-01
- Volume
- 19
- Issue
- 1
- Pages
- 25-32
- ISSN
- 1040-8711 (ISSN-L)
- OpenAlex
- W3024920818
- Cited by
- 236
- References
- 2
- FWCI
- 13.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Churg–Strauss syndrome. https://app.cochat.ai/papers/10.1097/bor.0b013e3280119854
- The paper
- Pagnoux, C., Guilpain, P., & Guillevin, L. (2007). Churg–Strauss syndrome. Current Opinion in Rheumatology. https://doi.org/10.1097/bor.0b013e3280119854
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.